SEC Form 5 · accession 0001387131-18-000566
TherapeuticsMD, Inc. · TXMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John C.K. Milligan IV
Officer — President/Secretary · Director
Period of report
Dec 31, 2017
Accepted (ET)
Feb 12, 2018 · 9:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000025743
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Mar 2, 2017 | G | 100,000 | $0.00 | D | 2,690,396 | I | See |
| Common StockF3,F2 | Nov 29, 2017 | G | 20,000 | $0.00 | D | 2,987,523 | I | See |
| Common Stock | holding | — | — | — | 1,472,419 | D | ||
| Common StockF1 | holding | — | — | — | 1,004,664 | I | See |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1By the Reporting Person's Grantor-Retained Annuity Trust (the "GRAT").
- F2By John C.K. Milligan Revocable Trust U/A 08/10/2009, as amended.
- F3Includes 317,127 shares of common stock previously reported as being held indirectly by the GRAT.